Target intelligence / Profile preview

Sirtuin family protein deacetylase (SIRT) (SIRT)

Target
SIRT
Molecular classification
Enzyme, Histone modification, Class III histone deacetylase, NAD-dependent deacetylase
01

Overview

The Sirtuin family protein deacetylases (SIRT1-7 in humans) are a group of NAD+-dependent enzymes that play a pivotal role in maintaining cellular homeostasis and regulating lifespan. These enzymes function as metabolic sensors, responding to changes in the NAD+/NADH ratio to modulate the acetylation state of various histone and non-histone targets, including p53, PGC-1alpha, and FOXO transcription factors (Source: NIH, PMC3836119). By linking metabolic status to gene expression and protein activity, sirtuins influence critical processes such as DNA repair, mitochondrial biogenesis, and apoptosis (Source: UniProt). In disease contexts, sirtuins are implicated in the pathogenesis of metabolic syndrome, neurodegeneration, and cancer, where they can act as either tumor suppressors or promoters depending on the tissue type (Source: PubMed, 21385879). Therapeutic strategies involve the use of sirtuin-activating compounds (STACs) like resveratrol to treat age-related diseases or specific inhibitors for oncology indications (Source: Nature Reviews Drug Discovery, 2022).

Other names
Silent information regulatorNAD-dependent protein deacetylaseSIR2-like proteinClass III histone deacetylaseHDAC Class III
02

Mechanism of action

NAD+-dependent deacetylation of lysine residues on histone and non-histone proteins, converting NAD+ and acetylated substrate into nicotinamide, 2'-O-acetyl-ADP-ribose, and the deacetylated product (Source: PubMed, 11158311).

03

Biological functions

MetabolismAgingDNA repairGene silencingStress responseApoptosisCell cycle regulationMitochondrial homeostasis
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMetabolic disorderInflammationType 2 diabetes
05

Safety considerations

Context-dependent role in cancer (tumor suppressor vs. promoter)Off-target effects across SIRT isoformsPotential for metabolic dysregulationLimited bioavailability of natural activators
06

Interacting drugs

Resveratrol

7 more in the full profile.

07

Biomarkers

NAD+ levelsp53 acetylation statusHistone H3K9 acetylationSIRT1 expression levelsPGC-1alpha acetylation status

Beyond the preview

Go deeper on Sirtuin family protein deacetylase (SIRT) (SIRT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirtuin family protein deacetylase (SIRT) (SIRT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call